Report - FONT Phase II Clinical Trial. Justification for Novel FSGS Therapy Poor Survival for Resistant FSGS Presler/Gipson, 2005 a. Pediatric FSGS CR 12 12 8.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form